India's resurgence of COVID-19: urgent actions needed

Aiyar, Yamini; Chandru, Vijay; Chatterjee, Mary; Desai, Sapna; Fernandez, Armida; Gupta, Atul; Kang, Gagandeep; Khanna, Tarun; Mazumdar-Shaw, Kiran; Mor, Nachiket; Mukherji, Arnab; Muttreja, Poonam; Narayan, Thelma; Patwardhan, Bhushan; Rao, Kefei; Sharma, Sharad; Shetty, Devi Prasad; Subramanian, Saumya; Varkey, Leila E Caleb; Venkateswaran, Sandhya; Patel, Vikram

doi:10.1016/s0140-6736(21)01202-2

Cited by 21 publications

(11 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…If not anything else, the second wave should teach the GoI the importance of vaccination and to boost the speed of COVID-19 immunisation to curb the spread of COVID-19 and avoid the projected 1.19 million deaths by October 2021. Apart from the suggestions provided in this study,Aiyar et al (27) and Kuppalli et al (28) can also be referred for other actions that need to be taken in order to avoid any more waves of COVID-19 in the country.…”

Section: Averting Any More Waves Of Covid-19mentioning

confidence: 92%

Strategies for COVID-19 Epidemiological Surveillance in India: Overall Policies Till June 2021

Ghosh

Saha

Sarkar

et al. 2021

Front. Public Health

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has gripped the entire world, almost paralysing the human race in its entirety. The virus rapidly transmits via human-to-human medium resulting in a massive increase of patients with COVID-19. In order to curb the spread of the disease, an immediate action of complete lockdown was implemented across the globe. India with a population of over 1.3 billion was not an exception and took the challenge to execute phase-wise lockdown, unlock and partial lockdown activities. In this study, we intend to summarise these different phases that the Government of India (GoI) imposed to fight against SARS-CoV-2 so that it can act as a reference guideline to help controlling future waves of COVID-19 and similar pandemic situations in India.

show abstract

Section: Averting Any More Waves Of Covid-19mentioning

confidence: 92%

Strategies for COVID-19 Epidemiological Surveillance in India: Overall Policies Till June 2021

Ghosh

Saha

Sarkar

et al. 2021

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…Another mutant, 501Y.V2 variant (B.1.351), was identified in South Africa on 5 October 2020 [46]. As of May 2021, the resurgent wave of COVID-19 in India has spread to rural populations and other countries in the region [47]. The B.1.617.2 variant was highlighted as a variant of interest by the WHO and is one of multiple variants currently circulating in India [48,49].…”

Section: Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2)mentioning

confidence: 99%

Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies

Hsieh

Lin

et al. 2021

Diagnostics

View full text Add to dashboard Cite

The COVID-19 pandemic is an ongoing global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020–2021. COVID-19 is becoming one of the most fatal pandemics in history and brings a huge challenge to the global healthcare system. Opportune detection, confinement, and early treatment of infected cases present the first step in combating COVID-19. Diagnosis via viral nucleic acid amplification tests (NAATs) is frequently employed and considered the standard procedure. However, with an increasing urge for point-of-care tests, rapid and cheaper immunoassays are widely utilized, such as lateral flow immunoassay (LFIA), which can be used for rapid, early, and large-scale detection of SARS-CoV-2 infection. In this narrative review, the principle and technique of LFIA applied in COVID-19 antigen and antibody detection are introduced. The diagnostic sensitivity and specificity of the commercial LFIA tests are outlined and compared. Generally, LFIA antigen tests for SARS-CoV-2 are less sensitive than viral NAATs, the “gold standard” for clinical COVID-19 diagnosis. However, antigen tests can be used for rapid and mass testing in high-risk congregate housing to quickly identify people with COVID-19, implementing infection prevention and control measures, thus preventing transmission. LFIA anti-SARS-CoV-2 antibody tests, IgM and/or IgG, known as serology tests, are used for identification if a person has previously been exposed to the virus or vaccine immunization. Notably, advanced techniques, such as LFT-based CRISPR-Cas9 and surface-enhanced Raman spectroscopy (SERS), have added new dimensions to the COVID-19 diagnosis and are also discussed in this review.

show abstract

“…In this commentary, we are looking at urgent actions that ECOWAS Countries can take to mitigate the impact of COVID-19 crisis on lives and livelihoods in West Africa. COVID-19 can be a very challenging situation with the occurrence of major COVID-19 crisis in many places around the world, West Africa needs to urgently learn from COVID-19 crisis that happened in Brazil, Peru and India in order to prepare adequately for a possible high surge of new COVID-19 cases [ 2 - 4 ]. Managing COVID-19 pandemic in this context require governments take decisive, quick and critical actions to predict, assess, prepare to respond to future waves of the pandemic.…”

Section: Commentarymentioning

confidence: 99%

COVID-19 pandemic waves: how prepared is West Africa for managing a high COVID-19 caseload? Urgent actions needed

Lokossou¹,

Umeokonkwo²,

Okolo³

et al. 2021

Pan Afr Med J

View full text Add to dashboard Cite

The ECOWAS Region and the world have learnt a lot in the last year and a half concerning the pandemic. As the pandemic continues to evolve, the region needs to put together all these lessons in other to better protect its people, rebuild its economy and strengthen the regional health security for better regional prosperity. We reviewed the response mounted by the region from January 2020 to July 2021 and the existing body of knowledge. We recommend that the region quickly increase the COVID-19 immunization coverage, sustain the enhance genomic surveillance, improve testing and the strengthen point of entry surveillance.

show abstract

India's resurgence of COVID-19: urgent actions needed

Abstract: India's resurgence of COVID-19: urgent actions neededFor the Lancet Citizens' Commission on Reimagining India's Health System see www. citizenshealth.in

Cited by 21 publications

References 5 publications

Strategies for COVID-19 Epidemiological Surveillance in India: Overall Policies Till June 2021

Strategies for COVID-19 Epidemiological Surveillance in India: Overall Policies Till June 2021

Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies

COVID-19 pandemic waves: how prepared is West Africa for managing a high COVID-19 caseload? Urgent actions needed

Contact Info

Product

Resources

About